Skip to main content
. 2024 Jun 13;10:45. doi: 10.1038/s41523-024-00646-2

Fig. 3. The clinical responses of two patients treated with palbociclib, trastuzumab, and pyrotinib with fulvestrant.

Fig. 3

a MRI/CT scans of tumor metastases in brain and lung during one cycles of combination treatment in patient 1. b MRI/CT scans of tumor metastases in brain and lung during 12 cycles of combination treatment in patient 2. c, d The dynamic change of CEA, CA125, CA153, and CA199 during combination treatment in patients 1 and 2.